This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Treatment

Authoring team

This condition is managed symptomatically; for example lengthening a shorter leg where there is a limb mismatch.

Recombinant human growth hormone may allow a better growth pattern in children with achondroplasia, especially when combined with l-thyroxine and surgical elongation of the tibia and/or femur (1)

Hydrocephalus should be managed appropriately.

All people with achondroplasia be followed up regularly to detect the significant complications that occur in approximately 10% of these children. (2)

References

  1. Wrobel W, Pach E, Ben-Skowronek I; Advantages and Disadvantages of Different Treatment Methods in Achondroplasia: A Review. Int J Mol Sci. 2021 May 25;22(11):5573
  2. Wright MJ, Irving MD; Clinical management of achondroplasia. Arch Dis Child. 2012 Feb;97(2):129-34.

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2025 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.